Hypoxia Integration in the Serological Proteome Analysis Unmasks Tumor Antigens and Fosters the Identification of Anti-Phospho-eEF2 Antibodies as Potential Cancer Biomarkers

• Marie Grandjean,

  Affiliation UCLouvain, Institut de Recherche Expérimentale et Clinique (IREC), Pole of Pharmacology and Therapeutics (FATH), Brussels, Belgium

  ⨯
• Alexandra Sermeus,

  Affiliation UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium

  ⨯
• Samuel Branders,

  Affiliation UCLouvain, Institute of Information and Communication Technologies, Electronics and Applied Mathematics (ICTEAM), Machine Learning Group, Louvain-la-Neuve, Belgium

  ⨯
• Florence Defresne,

  Affiliation UCLouvain, Institut de Recherche Expérimentale et Clinique (IREC), Pole of Pharmacology and Therapeutics (FATH), Brussels, Belgium

  ⨯
• Marc Dieu,

  Affiliation UNamur, Namur Research Institute for Life Sciences (NARILIS), Research Unit of Cell Biology (URBC), Namur, Belgium

  ⨯
• Pierre Dupont,

  Affiliation UCLouvain, Institute of Information and Communication Technologies, Electronics and Applied Mathematics (ICTEAM), Machine Learning Group, Louvain-la-Neuve, Belgium

  ⨯
• Martine Raes,

  Affiliation UNamur, Namur Research Institute for Life Sciences (NARILIS), Research Unit of Cell Biology (URBC), Namur, Belgium

  ⨯
• Mark De Ridder,

  Affiliation UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium

  ⨯
• Olivier Feron

  * E-mail: olivier.feron@uclouvain.be

  Affiliation UCLouvain, Institut de Recherche Expérimentale et Clinique (IREC), Pole of Pharmacology and Therapeutics (FATH), Brussels, Belgium

  ⨯